Pharma-Bio Serv, Inc. (PBSV) — 10-Q Filings

10-Q Filings (6)

• PBSV Narrows Losses by 87% YTD Despite Revenue Dip — Sep 15, 2025 Risk: medium
  Pharma-Bio Serv, Inc. (PBSV) reported a net loss of $204,250 for the three months ended July 31, 2025, a 33.9% improvement from the $309,194 net loss in the sam
• 10-Q Filing — Jun 16, 2025 Risk: medium
  Pharma-Bio Serv, Inc. (PBSV) reported a significant decline in revenue and a net loss for the three and six months ended April 30, 2025. For the three months, t
• Pharma-Bio Serv Q1 Sales Slightly Up, Assets Top $235M — Mar 17, 2025 Risk: low
  Pharma-Bio Serv, Inc. filed its 10-Q for the period ending January 31, 2025. The company reported net sales of $56.15 million for the first quarter of fiscal ye
• Pharma-Bio Serv, Inc. Files Q3 2024 10-Q — Sep 16, 2024 Risk: low
  Pharma-Bio Serv, Inc. filed its 10-Q for the period ending July 31, 2024. The company, formerly known as Lawrence Consulting Group Inc., operates in management
• Pharma-Bio Serv, Inc. Files Q2 2024 10-Q — Jun 14, 2024 Risk: low
  Pharma-Bio Serv, Inc. filed its 10-Q for the period ending April 30, 2024. The company, formerly known as LAWRENCE CONSULTING GROUP INC, is based in Dorado, PR.
• Pharma-Bio Serv, Inc. Files 10-Q for Period Ending January 31, 2024 — Mar 18, 2024 Risk: low
  Pharma-Bio Serv, Inc. (PBSV) filed a Quarterly Report (10-Q) with the SEC on March 18, 2024. Pharma-Bio Serv, Inc. filed a 10-Q report for the quarter ended Jan

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX